FDA approves PureTech’s obesity device PlenityThe FDA has approved PureTech Health’s ‘space occupying’ device Plenity as a new prescription treatment for obesity, setting Share XFDA approves PureTech’s obesity device Plenityhttps://pharmaphorum.com/news/fda-approves-puretech-obesity-plenity/
Gilead and Novo Nordisk collaborate for NASH trialGilead and Novo Nordisk have announced that they will collaborate on a clinical trial in nonalcoholic steatohepatitis (NASH) Share XGilead and Novo Nordisk collaborate for NASH trialhttps://pharmaphorum.com/news/gilead-and-novo-nordisk-collaborate-for-nash-trial/
Novo prevents Teva’s Victoza rival launch until 2023Novo Nordisk has settled a US patent case with Teva, which prevents the Israel-based generics firm marketing a Share XNovo prevents Teva’s Victoza rival launch until 2023https://pharmaphorum.com/news/novo-prevents-tevas-victoza-rival-launch-until-2023/
Novo Nordisk and Abbott announce digital diabetes tie-upNovo Nordisk and devices firm Abbott have announced a partnership that aims to make diabetes management easier by Share XNovo Nordisk and Abbott announce digital diabetes tie-uphttps://pharmaphorum.com/news/novo-nordisk-and-abbott-announced-digital-diabetes-tie-up/
No US launch until 2020 for Novo’s new haemophilia therapyThe US regulator has approved Novo Nordisk’s long-acting therapy for haemophilia A, Esperoct, as the Danish pharma seeks Share XNo US launch until 2020 for Novo’s new haemophilia therapyhttps://pharmaphorum.com/news/no-us-launch-until-2020-for-novos-new-haemophilia-therapy/
Novo accelerates launch plans for oral semaglutideNovo Nordisk has said it is accelerating launch preparations for its new diabetes pill semaglutide, after investing in Share XNovo accelerates launch plans for oral semaglutidehttps://pharmaphorum.com/news/novo-accelerates-launch-plans-for-oral-semaglutide/
Novo begins R&D tie-up with AI biotech e-TherapeuticsNovo Nordisk has signed a deal with UK biotech e-Therapeutics to use its AI-based drug discovery technology to Share XNovo begins R&D tie-up with AI biotech e-Therapeuticshttps://pharmaphorum.com/news/novo-begins-rd-tie-up-with-ai-biotech-e-therapeutics/
Novo Nordisk’s diabetes pill clears cardiac safety hurdleNovo Nordisk is set to file its daily semaglutide type 2 diabetes pill after it cleared a phase Share XNovo Nordisk’s diabetes pill clears cardiac safety hurdlehttps://pharmaphorum.com/news/novos-diabetes-pill-clears-cardiac-safety-hurdle-filings-to-follow/
Gene therapy firm BioMarin stages haemophilia musicalBioMarin Pharmaceutical has put on a stage musical to raise awareness about haemophilia, and determine whether creative expression Share XGene therapy firm BioMarin stages haemophilia musicalhttps://pharmaphorum.com/news/gene-therapy-firm-biomarin-stages-haemophilia-musical/
